Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d6f7da1e425c8a3ef1da21e08f4c196 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F16F1-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G05D16-2024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F16K31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/F16F1-34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate |
2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa3c41af4f42e2a3a95fc47f9464ed4 |
publicationDate |
2017-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2614826-T3 |
titleOfInvention |
Modulation of the blood brain barrier permeability |
abstract |
An adenosine A2A receptor agonist and / or an adenosine A1 receptor antagonist for use in increasing the permeability of the blood-brain barrier in a subject, where the subject is one who would benefit from an increase in the permeability of the blood-brain barrier and where the subject is not subjected to a treatment that increases the level of adenosine. |
priorityDate |
2008-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |